Oral 9169093 ? O
ingestion ? ? O
of ? ? O
mannose ? ? I-treatment
elevates ? ? O
blood ? ? O
mannose ? ? I-treatment
levels ? ? O
: ? ? O
a ? ? O
first ? ? O
step ? ? O
toward ? ? O
a ? ? O
potential ? ? O
therapy ? ? O
for ? ? O
carbohydrate-deficient ? ? I-disease
glycoprotein ? ? I-disease
syndrome ? ? I-disease
type ? ? I-disease
I ? ? I-disease
. ? ? O

Carbohydrate-deficient 9169093 ? I-disease
glycoprotein ? ? I-disease
syndrome ? ? I-disease
type ? ? I-disease
I ? ? I-disease
( ? ? O
CDGS ? ? I-disease
) ? ? O
is ? ? O
an ? ? O
inherited ? ? O
metabolic ? ? O
disorder ? ? O
with ? ? O
multisystemic ? ? I-disease
abnormalities ? ? I-disease
resulting ? ? O
from ? ? O
a ? ? O
failure ? ? O
to ? ? O
add ? ? O
entire ? ? O
N-linked ? ? O
oligosaccharide ? ? O
chains ? ? O
to ? ? O
many ? ? O
glycoproteins ? ? O
. ? ? O

Fibroblasts 9169093 ? O
from ? ? O
these ? ? O
patients ? ? O
also ? ? O
abnormally ? ? O
glycosylate ? ? O
proteins ? ? O
, ? ? O
but ? ? O
this ? ? O
lesion ? ? O
is ? ? O
corrected ? ? O
by ? ? O
providing ? ? O
250 ? ? O
microM ? ? O
mannose ? ? I-treatment
to ? ? O
the ? ? O
culture ? ? O
medium ? ? O
. ? ? O

This 9169093 ? O
correction ? ? O
of ? ? O
protein ? ? O
glycosylation ? ? O
suggests ? ? O
that ? ? O
providing ? ? O
dietary ? ? O
mannose ? ? I-treatment
to ? ? O
elevate ? ? O
blood ? ? O
mannose ? ? O
concentrations ? ? O
might ? ? O
also ? ? O
remedy ? ? O
some ? ? O
of ? ? O
the ? ? O
underglycosylation ? ? O
observed ? ? O
in ? ? O
these ? ? O
patients ? ? O
. ? ? O

We 9169093 ? O
find ? ? O
that ? ? O
ingested ? ? O
mannose ? ? I-treatment
is ? ? O
efficiently ? ? O
absorbed ? ? O
and ? ? O
increases ? ? O
blood ? ? O
mannose ? ? O
levels ? ? O
in ? ? O
both ? ? O
normal ? ? O
subjects ? ? O
and ? ? O
CDGS ? ? I-disease
patients ? ? O
. ? ? O

Blood 9169093 ? O
mannose ? ? I-treatment
levels ? ? O
increased ? ? O
in ? ? O
a ? ? O
dose-dependent ? ? O
fashion ? ? O
with ? ? O
increasing ? ? O
oral ? ? O
doses ? ? O
of ? ? O
mannose ? ? I-treatment
( ? ? O
0.07-0.21 ? ? O
g ? ? O
mannose ? ? I-treatment
/ ? ? O
kg ? ? O
body ? ? O
weight ? ? O
) ? ? O
. ? ? O

Peak 9169093 ? O
blood ? ? O
mannose ? ? I-treatment
concentrations ? ? O
occurred ? ? O
at ? ? O
1-2 ? ? O
h ? ? O
following ? ? O
ingestion ? ? O
and ? ? O
the ? ? O
clearance ? ? O
half-time ? ? O
was ? ? O
approximately ? ? O
4 ? ? O
h. ? ? O
Doses ? ? O
of ? ? O
0.1 ? ? O
g ? ? O
mannose ? ? I-treatment
/ ? ? O
kg ? ? O
body ? ? O
weight ? ? O
given ? ? O
at ? ? O
3-h ? ? O
intervals ? ? O
maintained ? ? O
blood ? ? O
mannose ? ? I-treatment
concentrations ? ? O
at ? ? O
levels ? ? O
3- ? ? O
to ? ? O
5-fold ? ? O
higher ? ? O
than ? ? O
the ? ? O
basal ? ? O
level ? ? O
in ? ? O
both ? ? O
normal ? ? O
controls ? ? O
( ? ? O
approximately ? ? O
55 ? ? O
microM ? ? O
) ? ? O
and ? ? O
CDGS ? ? I-disease
patients ? ? O
. ? ? O

No 9169093 ? O
side ? ? O
effects ? ? O
were ? ? O
observed ? ? O
for ? ? O
this ? ? O
dosage ? ? O
regimen ? ? O
. ? ? O

These 9169093 ? O
results ? ? O
establish ? ? O
the ? ? O
feasibility ? ? O
of ? ? O
using ? ? O
mannose ? ? I-treatment
as ? ? O
a ? ? O
potential ? ? O
therapeutic ? ? O
dietary ? ? O
supplement ? ? O
( ? ? O
nutraceutical ? ? O
) ? ? O
to ? ? O
treat ? ? O
CDGS ? ? I-disease
patients ? ? O
. ? ? O

Failure 9736238 ? O
of ? ? O
short-term ? ? O
mannose ? ? I-treatment
therapy ? ? O
of ? ? O
patients ? ? O
with ? ? O
carbohydrate-deficient ? ? I-disease
glycoprotein ? ? I-disease
syndrome ? ? I-disease
type ? ? I-disease
1A ? ? I-disease
. ? ? O

Carbohydrate-deficient 9736238 ? I-disease
glycoprotein ? ? I-disease
syndrome ? ? I-disease
type ? ? I-disease
1A ? ? I-disease
( ? ? O
CDGS1A ? ? I-disease
) ? ? O
is ? ? O
an ? ? O
inherited ? ? O
disorder ? ? O
with ? ? O
multisystemic ? ? I-disease
abnormalities ? ? I-disease
resulting ? ? O
from ? ? O
failure ? ? I-disease
to ? ? I-disease
generate ? ? I-disease
sufficient ? ? I-disease
lipid-linked ? ? I-disease
oligosaccharide ? ? I-disease
precursor ? ? I-disease
or ? ? I-disease
to ? ? I-disease
transfer ? ? I-disease
the ? ? I-disease
sugar ? ? I-disease
chain ? ? I-disease
to ? ? I-disease
many ? ? I-disease
glycoproteins ? ? I-disease
. ? ? O

Cultured 9736238 ? O
fibroblasts ? ? O
from ? ? O
these ? ? O
patients ? ? O
have ? ? O
reduced ? ? O
incorporation ? ? O
of ? ? O
mannose ? ? O
into ? ? O
glycoproteins ? ? O
which ? ? O
can ? ? O
be ? ? O
corrected ? ? O
by ? ? O
adding ? ? O
D-mannose ? ? I-treatment
to ? ? O
the ? ? O
culture ? ? O
medium ? ? O
. ? ? O

Providing 9736238 ? O
dietary ? ? I-treatment
mannose ? ? I-treatment
to ? ? O
elevate ? ? O
mannose ? ? O
concentrations ? ? O
in ? ? O
vivo ? ? O
therefore ? ? O
might ? ? O
remedy ? ? O
some ? ? O
of ? ? O
the ? ? O
underglycosylation ? ? O
in ? ? O
the ? ? O
patients ? ? O
. ? ? O

Five 9736238 ? O
children ? ? O
with ? ? O
CDGS1A ? ? I-disease
aged ? ? O
15 ? ? O
months ? ? O
to ? ? O
14 ? ? O
y ? ? O
completed ? ? O
a ? ? O
protocol ? ? O
of ? ? O
enteral ? ? O
supplementation ? ? O
with ? ? O
D-mannose ? ? I-treatment
100 ? ? I-treatment
mg ? ? I-treatment
/ ? ? I-treatment
kg ? ? I-treatment
every ? ? I-treatment
3 ? ? I-treatment
h ? ? I-treatment
for ? ? I-treatment
9 ? ? I-treatment
d. ? ? O
The ? ? O
mean ? ? O
S-mannose ? ? O
level ? ? O
increased ? ? O
from ? ? O
32 ? ? O
microM ? ? O
( ? ? O
range ? ? O
22-42 ? ? O
microM ? ? O
) ? ? O
to ? ? O
a ? ? O
trough ? ? O
value ? ? O
of ? ? O
72 ? ? O
microM ? ? O
( ? ? O
range ? ? O
39-103 ? ? O
microM ? ? O
) ? ? O
. ? ? O

No 9736238 ? O
serious ? ? O
side ? ? O
effects ? ? O
were ? ? O
observed ? ? O
. ? ? O

Surprisingly 9736238 ? O
, ? ? O
the ? ? O
mean ? ? O
serum ? ? O
concentration ? ? O
of ? ? O
four ? ? O
glycoproteins ? ? O
( ? ? O
transferrin ? ? I-gene
, ? ? O
alpha1-antitrypsin ? ? I-gene
, ? ? O
antithrombin ? ? I-gene
, ? ? O
and ? ? O
thyroxine-binding ? ? I-gene
globulin ? ? I-gene
) ? ? O
tended ? ? O
to ? ? O
decrease ? ? O
, ? ? O
and ? ? O
the ? ? O
mean ? ? O
serum ? ? O
concentration ? ? O
of ? ? O
carbohydrate-deficient ? ? O
transferrin ? ? I-gene
( ? ? O
CDT ? ? O
) ? ? O
increased ? ? O
. ? ? O

Furthermore 9736238 ? O
, ? ? O
the ? ? O
initially ? ? O
present ? ? O
abnormal ? ? O
isoforms ? ? O
of ? ? O
these ? ? O
glycoproteins ? ? O
and ? ? O
of ? ? O
protein ? ? I-gene
C ? ? I-gene
became ? ? O
more ? ? O
prominent ? ? O
and ? ? O
/ ? ? O
or ? ? O
additional ? ? O
abnormal ? ? O
isoforms ? ? O
appeared ? ? O
. ? ? O

This 9736238 ? O
short-term ? ? O
trial ? ? O
does ? ? O
not ? ? O
support ? ? O
a ? ? O
benefit ? ? O
of ? ? O
mannose ? ? I-treatment
to ? ? O
the ? ? O
deficient ? ? O
glycosylation ? ? O
of ? ? O
CDGS1A ? ? I-disease
patients ? ? O
. ? ? O

A 11134235 ? O
broad ? ? O
spectrum ? ? O
of ? ? O
clinical ? ? O
presentations ? ? O
in ? ? O
congenital ? ? I-disease
disorders ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
I ? ? I-disease
: ? ? O
a ? ? O
series ? ? O
of ? ? O
26 ? ? O
cases ? ? O
. ? ? O

INTRODUCTION 11134235 ? O
: ? ? O
Congenital ? ? I-disease
disorders ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
( ? ? O
CDG ? ? I-disease
) ? ? O
, ? ? O
or ? ? O
carbohydrate ? ? I-disease
deficient ? ? I-disease
glycoprotein ? ? I-disease
syndromes ? ? I-disease
, ? ? O
form ? ? O
a ? ? O
new ? ? O
group ? ? O
of ? ? O
multisystem ? ? I-disease
disorders ? ? I-disease
characterised ? ? O
by ? ? O
defective ? ? I-disease
glycoprotein ? ? I-disease
biosynthesis ? ? I-disease
, ? ? O
ascribed ? ? O
to ? ? O
various ? ? O
biochemical ? ? O
mechanisms ? ? O
. ? ? O

METHODS 11134235 ? O
: ? ? O
We ? ? O
report ? ? O
the ? ? O
clinical ? ? O
, ? ? O
biological ? ? O
, ? ? O
and ? ? O
molecular ? ? O
analysis ? ? O
of ? ? O
26 ? ? O
CDG ? ? I-disease
I ? ? I-disease
patients ? ? O
, ? ? O
including ? ? O
20 ? ? O
CDG ? ? I-disease
Ia ? ? I-disease
, ? ? O
two ? ? O
CDG ? ? I-disease
Ib ? ? I-disease
, ? ? O
one ? ? O
CDG ? ? I-disease
Ic ? ? I-disease
, ? ? O
and ? ? O
three ? ? O
CDG ? ? I-disease
Ix ? ? I-disease
, ? ? O
detected ? ? O
by ? ? O
western ? ? O
blotting ? ? O
and ? ? O
isoelectric ? ? O
focusing ? ? O
of ? ? O
serum ? ? O
transferrin ? ? I-gene
. ? ? O

RESULTS 11134235 ? O
: ? ? O
Based ? ? O
on ? ? O
the ? ? O
clinical ? ? O
features ? ? O
, ? ? O
CDG ? ? I-disease
Ia ? ? I-disease
could ? ? O
be ? ? O
split ? ? O
into ? ? O
two ? ? O
subtypes ? ? O
: ? ? O
a ? ? O
neurological ? ? I-disease
form ? ? I-disease
with ? ? O
psychomotor ? ? I-disease
retardation ? ? I-disease
, ? ? O
strabismus ? ? I-disease
, ? ? O
cerebellar ? ? I-disease
hypoplasia ? ? I-disease
, ? ? O
and ? ? O
retinitis ? ? I-disease
pigmentosa ? ? I-disease
( ? ? O
n=11 ? ? O
) ? ? O
, ? ? O
and ? ? O
a ? ? O
multivisceral ? ? I-disease
form ? ? I-disease
with ? ? O
neurological ? ? I-disease
and ? ? O
extraneurological ? ? I-disease
manifestations ? ? I-disease
including ? ? O
liver ? ? I-disease
, ? ? I-disease
cardiac ? ? I-disease
, ? ? I-disease
renal ? ? I-disease
, ? ? I-disease
or ? ? I-disease
gastrointestinal ? ? I-disease
involvement ? ? I-disease
( ? ? O
n=9 ? ? O
) ? ? O
. ? ? O

Interestingly 11134235 ? O
, ? ? O
dysmorphic ? ? I-disease
features ? ? I-disease
, ? ? O
inverted ? ? I-disease
nipples ? ? I-disease
, ? ? O
cerebellar ? ? I-disease
hypoplasia ? ? I-disease
, ? ? O
and ? ? O
abnormal ? ? I-disease
subcutaneous ? ? I-disease
fat ? ? I-disease
distribution ? ? I-disease
were ? ? O
not ? ? O
consistently ? ? O
observed ? ? O
in ? ? O
CDG ? ? I-disease
Ia ? ? I-disease
. ? ? O

By 11134235 ? O
contrast ? ? O
, ? ? O
the ? ? O
two ? ? O
CDG ? ? I-disease
Ib ? ? I-disease
patients ? ? O
had ? ? O
severe ? ? O
liver ? ? I-disease
disease ? ? I-disease
, ? ? O
enteropathy ? ? I-disease
, ? ? O
and ? ? O
hyperinsulinaemic ? ? I-disease
hypoglycaemia ? ? I-disease
but ? ? O
no ? ? I-disease
neurological ? ? I-disease
involvement ? ? I-disease
. ? ? O

Finally 11134235 ? O
, ? ? O
the ? ? O
CDG ? ? I-disease
Ic ? ? O
patient ? ? O
and ? ? O
one ? ? O
of ? ? O
the ? ? O
CDG ? ? I-disease
Ix ? ? I-disease
patients ? ? O
had ? ? O
psychomotor ? ? I-disease
retardation ? ? I-disease
and ? ? O
seizures ? ? I-disease
. ? ? O

The 11134235 ? O
other ? ? O
CDG ? ? I-disease
Ix ? ? I-disease
patients ? ? O
had ? ? O
severe ? ? I-disease
proximal ? ? I-disease
tubulopathy ? ? I-disease
, ? ? O
bilateral ? ? I-disease
cataract ? ? I-disease
, ? ? O
and ? ? O
white ? ? I-disease
matter ? ? I-disease
abnormalities ? ? I-disease
( ? ? O
one ? ? O
patient ? ? O
) ? ? O
, ? ? O
or ? ? O
multiorgan ? ? I-disease
failure ? ? I-disease
and ? ? O
multiple ? ? I-disease
birth ? ? I-disease
defects ? ? I-disease
( ? ? O
one ? ? O
patient ? ? O
) ? ? O
. ? ? O

CONCLUSIONS 11134235 ? O
: ? ? O
Owing ? ? O
to ? ? O
the ? ? O
remarkable ? ? O
clinical ? ? O
variability ? ? O
of ? ? O
CDG ? ? I-disease
, ? ? O
this ? ? O
novel ? ? O
disease ? ? O
probably ? ? O
remains ? ? O
largely ? ? O
underdiagnosed ? ? O
. ? ? O

The 11134235 ? O
successful ? ? O
treatment ? ? O
of ? ? O
CDG ? ? I-disease
Ib ? ? I-disease
patients ? ? O
with ? ? O
oral ? ? O
mannose ? ? I-treatment
emphasises ? ? O
the ? ? O
paramount ? ? O
importance ? ? O
of ? ? O
early ? ? O
diagnosis ? ? O
of ? ? O
PMI ? ? I-disease
deficiency ? ? I-disease
. ? ? O

Perturbation 11942856 ? O
of ? ? O
free ? ? O
oligosaccharide ? ? O
trafficking ? ? O
in ? ? O
endoplasmic ? ? O
reticulum ? ? O
glucosidase ? ? I-gene
I-deficient ? ? I-gene
and ? ? O
castanospermine-treated ? ? I-treatment
cells ? ? O
. ? ? O

Free 11942856 ? O
oligosaccharides ? ? O
( ? ? O
FOS ? ? O
) ? ? O
are ? ? O
generated ? ? O
both ? ? O
in ? ? O
the ? ? O
endoplasmic ? ? O
reticulum ? ? O
( ? ? O
ER ? ? O
) ? ? O
and ? ? O
in ? ? O
the ? ? O
cytosol ? ? O
during ? ? O
glycoprotein ? ? O
biosynthesis ? ? O
. ? ? O

ER 11942856 ? O
lumenal ? ? O
FOS ? ? O
possessing ? ? O
the ? ? O
di-N-acetylchitobiose ? ? O
moiety ? ? O
at ? ? O
their ? ? O
reducing ? ? O
termini ? ? O
( ? ? O
FOSGN2 ? ? O
) ? ? O
are ? ? O
exported ? ? O
into ? ? O
the ? ? O
cytosol ? ? O
where ? ? O
they ? ? O
, ? ? O
along ? ? O
with ? ? O
their ? ? O
cytosolically ? ? O
generated ? ? O
counterparts ? ? O
possessing ? ? O
a ? ? O
single ? ? O
N-acetylglucosamine ? ? O
residue ? ? O
at ? ? O
their ? ? O
reducing ? ? O
termini ? ? O
( ? ? O
FOSGN1 ? ? O
) ? ? O
, ? ? O
are ? ? O
trimmed ? ? O
in ? ? O
order ? ? O
to ? ? O
be ? ? O
imported ? ? O
into ? ? O
lysosomes ? ? O
for ? ? O
final ? ? O
degradation ? ? O
. ? ? O

Both 11942856 ? O
the ? ? O
ER ? ? O
and ? ? O
lysosomal ? ? O
FOS ? ? O
transport ? ? O
processes ? ? O
are ? ? O
unable ? ? O
to ? ? O
translocate ? ? O
triglucosylated ? ? O
FOS ? ? O
across ? ? O
membranes ? ? O
. ? ? O

In 11942856 ? O
the ? ? O
present ? ? O
study ? ? O
, ? ? O
we ? ? O
have ? ? O
examined ? ? O
FOS ? ? O
trafficking ? ? O
in ? ? O
HepG2 ? ? O
cells ? ? O
treated ? ? O
with ? ? O
the ? ? O
glucosidase ? ? I-gene
inhibitor ? ? O
castanospermine ? ? I-treatment
. ? ? O

We 11942856 ? O
have ? ? O
shown ? ? O
that ? ? O
triglucosylated ? ? O
FOSGN2 ? ? O
generated ? ? O
in ? ? O
the ? ? O
ER ? ? O
are ? ? O
transported ? ? O
to ? ? O
the ? ? O
Golgi ? ? O
apparatus ? ? O
where ? ? O
they ? ? O
are ? ? O
deglucosylated ? ? O
by ? ? O
endomannosidase ? ? I-gene
and ? ? O
acquire ? ? O
complex ? ? O
, ? ? O
sialic ? ? O
acid-containing ? ? O
structures ? ? O
before ? ? O
being ? ? O
secreted ? ? O
into ? ? O
the ? ? O
extracellular ? ? O
space ? ? O
by ? ? O
a ? ? O
Brefeldin ? ? I-treatment
A-sensitive ? ? I-treatment
pathway ? ? O
. ? ? O

FOSGN2 11942856 ? O
are ? ? O
also ? ? O
secreted ? ? O
from ? ? O
glucosidase ? ? O
I-deficient ? ? O
Lec23 ? ? O
cells ? ? O
and ? ? O
from ? ? O
the ? ? O
castanospermine-treated ? ? I-treatment
parental ? ? O
Chinese-hamster ? ? O
ovary ? ? O
cell ? ? O
line ? ? O
. ? ? O

Despite 11942856 ? O
the ? ? O
secretion ? ? O
of ? ? O
FOSGN2 ? ? O
from ? ? O
Lec23 ? ? O
cells ? ? O
, ? ? O
we ? ? O
noted ? ? O
a ? ? O
transient ? ? O
intracellular ? ? O
accumulation ? ? O
( ? ? O
60 ? ? O
nmol ? ? O
/ ? ? O
g ? ? O
cells ? ? O
) ? ? O
of ? ? O
triglucosylated ? ? O
FOSGN1 ? ? O
in ? ? O
these ? ? O
cells ? ? O
. ? ? O

Finally 11942856 ? O
, ? ? O
in ? ? O
glucosidase ? ? I-gene
I-compromised ? ? I-gene
cells ? ? O
, ? ? O
FOS ? ? O
trafficking ? ? O
was ? ? O
severely ? ? O
perturbed ? ? O
leading ? ? O
to ? ? O
both ? ? O
the ? ? O
secretion ? ? O
of ? ? O
FOSGN2 ? ? O
into ? ? O
the ? ? O
extracellular ? ? O
space ? ? O
and ? ? O
a ? ? O
growth-dependent ? ? O
pile ? ? O
up ? ? O
of ? ? O
triglucosylated ? ? O
FOSGN1 ? ? O
in ? ? O
the ? ? O
cytosol ? ? O
. ? ? O

The 11942856 ? O
possibility ? ? O
that ? ? O
these ? ? O
abnormalities ? ? O
contributed ? ? O
to ? ? O
the ? ? O
severe ? ? O
and ? ? O
rapidly ? ? O
progressive ? ? O
pathology ? ? O
in ? ? O
a ? ? O
patient ? ? O
with ? ? O
congenital ? ? I-disease
disorders ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
type ? ? I-disease
IIb ? ? I-disease
( ? ? O
glucosidase ? ? I-disease
I ? ? I-disease
deficiency ? ? I-disease
) ? ? O
is ? ? O
discussed ? ? O
. ? ? O

Cardiac 14627322 ? I-disease
manifestations ? ? I-disease
of ? ? O
carbohydrate-deficient ? ? I-disease
glycoprotein ? ? I-disease
syndrome ? ? I-disease
. ? ? O

A 14627322 ? O
2-month-old ? ? O
girl ? ? O
with ? ? O
exudative ? ? I-disease
pericarditis ? ? I-disease
and ? ? O
hypertrophic ? ? I-disease
obstructive ? ? I-disease
cardiomyopathy ? ? I-disease
is ? ? O
presented ? ? O
. ? ? O

The 14627322 ? O
child ? ? O
had ? ? O
characteristic ? ? O
dysmorphic ? ? I-disease
features ? ? I-disease
of ? ? O
carbohydrate-deficient ? ? I-disease
glycoprotein ? ? I-disease
syndrome ? ? I-disease
, ? ? O
which ? ? O
was ? ? O
confirmed ? ? O
by ? ? O
serum ? ? I-disease
levels ? ? I-disease
of ? ? I-disease
carbohydrate-deficient ? ? I-disease
transferrin ? ? I-disease
. ? ? O

Mutation 15107842 ? O
of ? ? O
the ? ? O
COG ? ? I-gene
complex ? ? O
subunit ? ? O
gene ? ? O
COG7 ? ? I-gene
causes ? ? O
a ? ? O
lethal ? ? I-disease
congenital ? ? I-disease
disorder ? ? I-disease
. ? ? O

The 15107842 ? O
congenital ? ? I-disease
disorders ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
( ? ? O
CDG ? ? I-disease
) ? ? O
are ? ? O
characterized ? ? O
by ? ? O
defects ? ? I-disease
in ? ? I-disease
N-linked ? ? I-disease
glycan ? ? I-disease
biosynthesis ? ? I-disease
that ? ? O
result ? ? O
from ? ? O
mutations ? ? O
in ? ? O
genes ? ? O
encoding ? ? O
proteins ? ? O
directly ? ? O
involved ? ? O
in ? ? O
the ? ? O
glycosylation ? ? O
pathway ? ? O
. ? ? O

Here 15107842 ? O
we ? ? O
describe ? ? O
two ? ? O
siblings ? ? O
with ? ? O
a ? ? O
fatal ? ? O
form ? ? O
of ? ? O
CDG ? ? I-disease
caused ? ? O
by ? ? O
a ? ? O
mutation ? ? O
in ? ? O
the ? ? O
gene ? ? O
encoding ? ? O
COG-7 ? ? I-gene
, ? ? O
a ? ? O
subunit ? ? O
of ? ? O
the ? ? O
conserved ? ? O
oligomeric ? ? O
Golgi ? ? O
( ? ? O
COG ? ? I-gene
) ? ? O
complex ? ? O
. ? ? O

The 15107842 ? O
mutation ? ? O
impairs ? ? O
integrity ? ? O
of ? ? O
the ? ? O
COG ? ? I-gene
complex ? ? O
and ? ? O
alters ? ? O
Golgi ? ? O
trafficking ? ? O
, ? ? O
resulting ? ? O
in ? ? O
disruption ? ? I-disease
of ? ? I-disease
multiple ? ? I-disease
glycosylation ? ? I-disease
pathways ? ? I-disease
. ? ? O

These 15107842 ? O
cases ? ? O
represent ? ? O
a ? ? O
new ? ? O
type ? ? O
of ? ? O
CDG ? ? I-disease
in ? ? O
which ? ? O
the ? ? O
molecular ? ? O
defect ? ? O
lies ? ? O
in ? ? O
a ? ? O
protein ? ? O
that ? ? O
affects ? ? O
the ? ? O
trafficking ? ? O
and ? ? O
function ? ? O
of ? ? O
the ? ? O
glycosylation ? ? O
machinery ? ? O
. ? ? O

Carbohydrate 15361947 ? I-disease
deficient ? ? I-disease
glycoprotein ? ? I-disease
syndrome ? ? I-disease
type ? ? I-disease
Ia ? ? I-disease
. ? ? O

Carbohydrate 15361947 ? I-disease
deficient ? ? I-disease
glycoprotein ? ? I-disease
syndromes ? ? I-disease
( ? ? O
CDG ? ? I-disease
) ? ? O
are ? ? O
inherited ? ? I-disease
multisystem ? ? I-disease
disorders ? ? I-disease
characterized ? ? O
by ? ? O
the ? ? O
abnormal ? ? I-disease
glycosylation ? ? I-disease
of ? ? I-disease
a ? ? I-disease
number ? ? I-disease
of ? ? I-disease
serum ? ? I-disease
glycoproteins ? ? I-disease
. ? ? O

CDG-Ia 15361947 ? I-disease
results ? ? O
from ? ? O
deficiency ? ? O
of ? ? O
phosphomannomutase ? ? I-gene
that ? ? O
catalyzes ? ? O
the ? ? O
conversion ? ? O
of ? ? O
mannose-6-phosphate ? ? O
to ? ? O
mannose-1-phosphate ? ? O
in ? ? O
the ? ? O
cytosol ? ? O
. ? ? O

We 15361947 ? O
report ? ? O
a ? ? O
case ? ? O
of ? ? O
CDG-Ia ? ? I-disease
in ? ? O
an ? ? O
11-month-old ? ? O
girl ? ? O
with ? ? O
developmental ? ? I-disease
delay ? ? I-disease
, ? ? O
failure ? ? I-disease
to ? ? I-disease
thrive ? ? I-disease
, ? ? O
inverted ? ? I-disease
nipples ? ? I-disease
and ? ? O
abnormal ? ? I-disease
fat ? ? I-disease
pads ? ? I-disease
. ? ? O

The 15361947 ? O
abnormal ? ? O
pattern ? ? O
of ? ? O
transferrin ? ? I-gene
glycosylation ? ? O
and ? ? O
phosphomannomutase ? ? I-gene
activity ? ? O
assay ? ? O
confirmed ? ? O
the ? ? O
diagnosis ? ? O
of ? ? O
CDG ? ? I-disease
type ? ? I-disease
Ia ? ? I-disease
. ? ? O

Unfortunately 15361947 ? O
, ? ? O
an ? ? O
efficient ? ? O
treatment ? ? O
is ? ? O
still ? ? O
not ? ? O
available ? ? O
for ? ? O
CDG ? ? I-disease
type ? ? I-disease
Ia ? ? I-disease
patients ? ? O
. ? ? O

This 15361947 ? O
is ? ? O
the ? ? O
first ? ? O
report ? ? O
of ? ? O
a ? ? O
Taiwanese ? ? O
patient ? ? O
with ? ? O
this ? ? O
syndrome ? ? O
. ? ? O

Glycoproteomics 15912511 ? O
of ? ? O
N-glycosylation ? ? O
by ? ? O
in-gel ? ? O
deglycosylation ? ? O
and ? ? O
matrix-assisted ? ? O
laser ? ? O
desorption ? ? O
/ ? ? O
ionisation-time ? ? O
of ? ? O
flight ? ? O
mass ? ? O
spectrometry ? ? O
mapping ? ? O
: ? ? O
application ? ? O
to ? ? O
congenital ? ? I-disease
disorders ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
. ? ? O

A 15912511 ? O
general ? ? O
strategy ? ? O
for ? ? O
the ? ? O
structural ? ? O
evaluation ? ? O
of ? ? O
N-glycosylation ? ? O
, ? ? O
a ? ? O
common ? ? O
post-translational ? ? O
protein ? ? O
modification ? ? O
, ? ? O
is ? ? O
presented ? ? O
. ? ? O

The 15912511 ? O
methods ? ? O
for ? ? O
the ? ? O
release ? ? O
of ? ? O
N-linked ? ? O
glycans ? ? O
from ? ? O
the ? ? O
gel-separated ? ? O
proteins ? ? O
, ? ? O
their ? ? O
isolation ? ? O
, ? ? O
purification ? ? O
and ? ? O
matrix-assisted ? ? O
laser ? ? O
desorption ? ? O
/ ? ? O
ionisation-mass ? ? O
spectrometry ? ? O
( ? ? O
MALDI-MS ? ? O
) ? ? O
analysis ? ? O
of ? ? O
their ? ? O
mixtures ? ? O
were ? ? O
optimised ? ? O
. ? ? O

Since 15912511 ? O
many ? ? O
glycoproteins ? ? O
are ? ? O
available ? ? O
only ? ? O
at ? ? O
low ? ? O
quantities ? ? O
from ? ? O
sodium ? ? O
dodecyl ? ? O
sulphate-polyacrylamide ? ? O
gel ? ? O
electrophoresis ? ? O
or ? ? O
two-dimensional ? ? O
gels ? ? O
, ? ? O
high ? ? O
attention ? ? O
was ? ? O
paid ? ? O
to ? ? O
obtain ? ? O
N-glycan ? ? O
mixtures ? ? O
representing ? ? O
their ? ? O
actual ? ? O
composition ? ? O
in ? ? O
human ? ? O
plasma ? ? O
by ? ? O
in-gel ? ? O
deglycosylation ? ? O
. ? ? O

The 15912511 ? O
relative ? ? O
sensitivity ? ? O
of ? ? O
solid ? ? O
MALDI ? ? O
matrices ? ? O
for ? ? O
MS ? ? O
analysis ? ? O
of ? ? O
acidic ? ? O
N-glycans ? ? O
was ? ? O
compared ? ? O
. ? ? O

The 15912511 ? O
most ? ? O
favourable ? ? O
results ? ? O
for ? ? O
native ? ? O
acidic ? ? O
N-glycans ? ? O
were ? ? O
obtained ? ? O
with ? ? O
2,4,6-trihydroxyacetophenone ? ? O
monohydrate ? ? O
/ ? ? O
diammoniumcitrate ? ? O
as ? ? O
a ? ? O
matrix ? ? O
. ? ? O

This 15912511 ? O
matrix ? ? O
provided ? ? O
good ? ? O
results ? ? O
for ? ? O
both ? ? O
neutral ? ? O
and ? ? O
acidic ? ? O
mixtures ? ? O
as ? ? O
well ? ? O
as ? ? O
for ? ? O
methylated ? ? O
N-glycans ? ? O
. ? ? O

In 15912511 ? O
the ? ? O
second ? ? O
part ? ? O
of ? ? O
this ? ? O
paper ? ? O
the ? ? O
potential ? ? O
of ? ? O
such ? ? O
an ? ? O
optimised ? ? O
MS ? ? O
strategy ? ? O
alone ? ? O
or ? ? O
in ? ? O
combination ? ? O
with ? ? O
high ? ? O
pH ? ? O
anion-exchange ? ? O
chromatography ? ? O
profiling ? ? O
for ? ? O
the ? ? O
clinical ? ? O
diagnosis ? ? O
of ? ? O
congenital ? ? I-disease
disorders ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
is ? ? O
presented ? ? O
. ? ? O

Clinical 16151902 ? O
and ? ? O
biochemical ? ? O
presentation ? ? O
of ? ? O
siblings ? ? O
with ? ? O
COG-7 ? ? I-disease
deficiency ? ? I-disease
, ? ? O
a ? ? O
lethal ? ? O
multiple ? ? O
O- ? ? I-disease
and ? ? I-disease
N-glycosylation ? ? I-disease
disorder ? ? I-disease
. ? ? O

Congenital 16151902 ? I-disease
disorders ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
( ? ? O
CDG ? ? I-disease
) ? ? O
represent ? ? O
a ? ? O
group ? ? O
of ? ? O
inherited ? ? I-disease
multiorgan ? ? I-disease
diseases ? ? I-disease
caused ? ? I-disease
by ? ? I-disease
defects ? ? I-disease
in ? ? I-disease
the ? ? I-disease
biosynthesis ? ? I-disease
of ? ? I-disease
glycoproteins ? ? I-disease
. ? ? O

We 16151902 ? O
report ? ? O
on ? ? O
two ? ? O
dysmorphic ? ? O
siblings ? ? O
with ? ? O
severe ? ? O
liver ? ? I-disease
disease ? ? I-disease
who ? ? O
died ? ? O
at ? ? O
the ? ? O
age ? ? O
of ? ? O
a ? ? O
few ? ? O
weeks ? ? O
. ? ? O

Increased 16151902 ? I-disease
activities ? ? I-disease
of ? ? I-disease
lysosomal ? ? I-disease
enzymes ? ? I-disease
in ? ? I-disease
plasma ? ? I-disease
were ? ? O
found ? ? O
, ? ? O
though ? ? O
total ? ? I-disease
sialic ? ? I-disease
acid ? ? I-disease
in ? ? I-disease
plasma ? ? I-disease
was ? ? I-disease
strongly ? ? I-disease
decreased ? ? I-disease
. ? ? O

Isoelectric 16151902 ? O
focusing ? ? O
of ? ? O
serum ? ? O
sialotransferrins ? ? O
showed ? ? O
a ? ? O
type ? ? I-disease
2-like ? ? I-disease
CDG ? ? I-disease
pattern ? ? O
. ? ? O

Some 16151902 ? O
of ? ? O
the ? ? O
known ? ? O
CDG ? ? I-disease
subtypes ? ? O
were ? ? O
excluded ? ? O
. ? ? O

O-Glycosylation 16151902 ? O
was ? ? O
investigated ? ? O
by ? ? O
isoelectric ? ? O
focusing ? ? O
of ? ? O
apolipoprotein ? ? I-gene
C-III ? ? I-gene
, ? ? O
which ? ? I-disease
showed ? ? I-disease
increased ? ? I-disease
fractions ? ? I-disease
of ? ? I-disease
hyposialylated ? ? I-disease
isoforms ? ? I-disease
. ? ? O

In 16151902 ? O
a ? ? O
consecutive ? ? O
study ? ? O
a ? ? I-disease
defect ? ? I-disease
in ? ? I-disease
the ? ? I-disease
conserved ? ? I-disease
oligomeric ? ? I-disease
Golgi ? ? I-disease
complex ? ? I-disease
was ? ? O
established ? ? O
at ? ? O
the ? ? O
level ? ? O
of ? ? O
subunit ? ? O
COG-7 ? ? I-gene
, ? ? O
leading ? ? O
to ? ? O
disruption ? ? I-disease
of ? ? I-disease
multiple ? ? I-disease
glycosylation ? ? I-disease
functions ? ? I-disease
of ? ? I-disease
the ? ? I-disease
Golgi ? ? I-disease
. ? ? O

This 16151902 ? O
report ? ? O
on ? ? O
patients ? ? O
with ? ? O
a ? ? O
new ? ? O
variant ? ? O
of ? ? O
CDG ? ? I-disease
, ? ? O
due ? ? O
to ? ? O
a ? ? O
multiple ? ? I-disease
Golgi ? ? I-disease
defect ? ? I-disease
, ? ? O
emphasizes ? ? O
in ? ? O
addition ? ? O
to ? ? O
sialotransferrins ? ? I-gene
the ? ? O
importance ? ? O
of ? ? O
analysis ? ? O
of ? ? O
a ? ? O
serum ? ? O
O-linked ? ? O
glycoprotein ? ? O
, ? ? O
e.g ? ? O
. ? ? O

apolipoprotein 16151902 ? I-gene
C-III ? ? I-gene
, ? ? O
in ? ? O
unclassified ? ? O
CDG-X ? ? I-disease
cases ? ? O
. ? ? O

Congenital 17451957 ? I-disease
disorder ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
type ? ? I-disease
1a ? ? I-disease
: ? ? O
three ? ? O
siblings ? ? O
with ? ? O
a ? ? O
mild ? ? I-disease
neurological ? ? I-disease
phenotype ? ? I-disease
. ? ? O

We 17451957 ? O
report ? ? O
3 ? ? O
siblings ? ? O
( ? ? O
1 ? ? O
male ? ? O
and ? ? O
2 ? ? O
female ? ? O
) ? ? O
recently ? ? O
diagnosed ? ? O
with ? ? O
congenital ? ? I-disease
disorder ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
type ? ? I-disease
Ia ? ? I-disease
( ? ? O
CDG-Ia ? ? I-disease
) ? ? O
in ? ? O
their ? ? O
mid-20s ? ? O
. ? ? O

They 17451957 ? O
experience ? ? O
mild ? ? I-disease
mental ? ? I-disease
retardation ? ? I-disease
but ? ? O
manage ? ? O
to ? ? O
function ? ? O
independently ? ? O
in ? ? O
society ? ? O
. ? ? O

Their 17451957 ? O
professions ? ? O
are ? ? O
library ? ? O
assistant ? ? O
, ? ? O
professional ? ? O
artistic ? ? O
painter ? ? O
and ? ? O
secretarial ? ? O
work ? ? O
. ? ? O

All 17451957 ? O
three ? ? O
siblings ? ? O
have ? ? O
cerebellar ? ? I-disease
hypoplasia ? ? I-disease
and ? ? O
ataxia ? ? I-disease
, ? ? O
but ? ? O
are ? ? O
able ? ? O
to ? ? O
ambulate ? ? O
easily ? ? O
. ? ? O

Two 17451957 ? O
of ? ? O
the ? ? O
siblings ? ? O
have ? ? O
required ? ? O
strabismus ? ? I-disease
surgical ? ? O
repairs ? ? O
. ? ? O

All 17451957 ? O
have ? ? O
antithrombin ? ? I-disease
III ? ? I-disease
deficiency ? ? I-disease
, ? ? O
osteoporosis ? ? I-disease
, ? ? O
and ? ? O
mild ? ? I-disease
dysmorphic ? ? I-disease
features ? ? I-disease
. ? ? O

Hypergonadotrophic 17451957 ? I-disease
hypogonadism ? ? I-disease
was ? ? O
a ? ? O
feature ? ? O
of ? ? O
the ? ? O
two ? ? O
female ? ? O
siblings ? ? O
. ? ? O

A 17451957 ? O
type ? ? I-disease
1 ? ? I-disease
sialotransferrin ? ? I-disease
pattern ? ? I-disease
and ? ? O
phosphomannomutase ? ? I-disease
( ? ? I-disease
PMM ? ? I-disease
) ? ? I-disease
deficiency ? ? I-disease
have ? ? O
been ? ? O
demonstrated ? ? O
. ? ? O

They 17451957 ? O
are ? ? O
compound ? ? O
heterozygotes ? ? O
for ? ? O
R141H ? ? O
and ? ? O
L32R ? ? O
mutations ? ? O
in ? ? O
the ? ? O
PMM2 ? ? I-gene
gene ? ? O
. ? ? O

While 17451957 ? O
there ? ? O
is ? ? O
clinical ? ? O
heterogeneity ? ? O
in ? ? O
CDG-Ia ? ? I-disease
, ? ? O
we ? ? O
believe ? ? O
that ? ? O
our ? ? O
patients ? ? O
are ? ? O
among ? ? O
the ? ? O
mildest ? ? O
of ? ? O
intellectually ? ? O
affected ? ? O
CDG-Ia ? ? I-disease
patients ? ? O
reported ? ? O
to ? ? O
date ? ? O
. ? ? O

N-glycosylation 17823199 ? O
site ? ? O
occupancy ? ? O
in ? ? O
serum ? ? O
glycoproteins ? ? O
using ? ? O
multiple ? ? O
reaction ? ? O
monitoring ? ? O
liquid ? ? O
chromatography-mass ? ? O
spectrometry ? ? O
. ? ? O

Congenital 17823199 ? I-disease
disorders ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
( ? ? O
CDGs ? ? I-disease
) ? ? O
are ? ? O
a ? ? O
family ? ? O
of ? ? O
N-linked ? ? I-disease
glycosylation ? ? I-disease
defects ? ? I-disease
associated ? ? O
with ? ? O
severe ? ? O
clinical ? ? O
manifestations ? ? O
. ? ? O

In 17823199 ? O
CDG ? ? I-disease
type-I ? ? I-disease
, ? ? O
deficiency ? ? O
of ? ? O
lipid-linked ? ? O
oligosaccharide ? ? O
assembly ? ? O
leads ? ? O
to ? ? O
the ? ? O
underoccupancy ? ? O
of ? ? O
N-glycosylation ? ? O
sites ? ? O
on ? ? O
glycoproteins ? ? O
. ? ? O

Although 17823199 ? O
the ? ? O
level ? ? O
of ? ? O
residual ? ? O
glycosylation ? ? O
activity ? ? O
is ? ? O
known ? ? O
to ? ? O
correlate ? ? O
with ? ? O
the ? ? O
clinical ? ? O
phenotype ? ? O
linked ? ? O
to ? ? O
individual ? ? O
CDG ? ? I-disease
mutations ? ? O
, ? ? O
it ? ? O
is ? ? O
not ? ? O
known ? ? O
whether ? ? O
the ? ? O
degree ? ? O
of ? ? O
N-glycosylation ? ? O
site ? ? O
occupancy ? ? O
by ? ? O
itself ? ? O
correlates ? ? O
with ? ? O
the ? ? O
severity ? ? O
of ? ? O
the ? ? O
disease ? ? O
. ? ? O

To 17823199 ? O
quantify ? ? O
the ? ? O
extent ? ? O
of ? ? O
underglycosylation ? ? O
in ? ? O
healthy ? ? O
control ? ? O
and ? ? O
in ? ? O
CDG ? ? I-disease
samples ? ? O
, ? ? O
we ? ? O
developed ? ? O
a ? ? O
quantitative ? ? O
method ? ? O
of ? ? O
N-glycosylation ? ? O
site ? ? O
occupancy ? ? O
based ? ? O
on ? ? O
multiple ? ? O
reaction ? ? O
monitoring ? ? O
LC-MS ? ? O
/ ? ? O
MS ? ? O
. ? ? O

Using 17823199 ? O
isotopically ? ? O
labeled ? ? O
standard ? ? O
peptides ? ? O
, ? ? O
we ? ? O
directly ? ? O
quantified ? ? O
the ? ? O
level ? ? O
of ? ? O
N-glycosylation ? ? O
site ? ? O
occupancy ? ? O
on ? ? O
selected ? ? O
serum ? ? O
proteins ? ? O
. ? ? O

In 17823199 ? O
healthy ? ? O
control ? ? O
samples ? ? O
, ? ? O
we ? ? O
determined ? ? O
98-100 ? ? O
% ? ? O
occupancy ? ? O
for ? ? O
all ? ? O
N-glycosylation ? ? O
sites ? ? O
of ? ? O
transferrin ? ? I-gene
and ? ? O
alpha ? ? I-gene
( ? ? I-gene
1 ? ? I-gene
) ? ? I-gene
-antitrypsin ? ? I-gene
. ? ? O

In 17823199 ? O
CDG ? ? I-disease
type-I ? ? I-disease
samples ? ? O
, ? ? O
we ? ? O
observed ? ? O
a ? ? O
reduction ? ? O
in ? ? O
N-glycosylation ? ? O
site ? ? O
occupancy ? ? O
that ? ? O
correlated ? ? O
with ? ? O
the ? ? O
severity ? ? O
of ? ? O
the ? ? O
disease ? ? O
. ? ? O

In 17823199 ? O
addition ? ? O
, ? ? O
we ? ? O
noticed ? ? O
a ? ? O
selective ? ? O
underglycosylation ? ? O
of ? ? O
N-glycosylation ? ? O
sites ? ? O
, ? ? O
indicating ? ? O
preferential ? ? O
glycosylation ? ? O
of ? ? O
acceptor ? ? O
sequons ? ? O
of ? ? O
a ? ? O
given ? ? O
glycoprotein ? ? O
. ? ? O

In 17823199 ? O
transferrin ? ? I-gene
, ? ? O
a ? ? O
preferred ? ? O
occupancy ? ? O
for ? ? O
the ? ? O
first ? ? O
N-glycosylation ? ? O
site ? ? O
was ? ? O
observed ? ? O
, ? ? O
and ? ? O
a ? ? O
decreasing ? ? O
preference ? ? O
for ? ? O
the ? ? O
first ? ? O
, ? ? O
third ? ? O
, ? ? O
and ? ? O
second ? ? O
N-glycosylation ? ? O
sites ? ? O
was ? ? O
observed ? ? O
in ? ? O
alpha ? ? I-gene
( ? ? I-gene
1 ? ? I-gene
) ? ? I-gene
-antitrypsin ? ? I-gene
. ? ? O

This 17823199 ? O
multiple ? ? O
reaction ? ? O
monitoring ? ? O
LC-MS ? ? O
/ ? ? O
MS ? ? O
method ? ? O
can ? ? O
be ? ? O
extended ? ? O
to ? ? O
multiple ? ? O
glycoproteins ? ? O
, ? ? O
thereby ? ? O
enabling ? ? O
a ? ? O
glycoproteomics ? ? O
survey ? ? O
of ? ? O
N-glycosylation ? ? O
site ? ? O
occupancies ? ? O
in ? ? O
biological ? ? O
samples ? ? O
. ? ? O

[ 18928705 ? O
Congenital ? ? I-disease
disorder ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
type ? ? I-disease
1b ? ? I-disease
. ? ? O

Experience 18928705 ? O
with ? ? O
mannose ? ? I-treatment
treatment ? ? I-treatment
] ? ? O
. ? ? O

Congenital 18928705 ? I-disease
disorders ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
( ? ? O
CDG ? ? I-disease
) ? ? O
are ? ? O
recessively ? ? O
inherited ? ? O
multisystemic ? ? I-disease
disorders ? ? I-disease
resulting ? ? O
from ? ? O
several ? ? O
genetic ? ? O
defects ? ? O
affecting ? ? O
the ? ? O
assembly ? ? O
, ? ? O
transfer ? ? O
or ? ? O
processing ? ? O
of ? ? O
oligosaccharides ? ? O
onto ? ? O
proteins ? ? O
and ? ? O
other ? ? O
glycoconjugates ? ? O
. ? ? O

CDG 18928705 ? I-disease
type ? ? I-disease
Ib ? ? I-disease
is ? ? O
due ? ? O
to ? ? O
a ? ? O
deficiency ? ? O
of ? ? O
phosphomannose ? ? I-gene
isomerase ? ? I-gene
( ? ? O
PMI ? ? I-gene
) ? ? O
encoded ? ? O
by ? ? O
the ? ? O
MPI ? ? I-gene
gene ? ? O
. ? ? O

PMI 18928705 ? I-gene
catalyzes ? ? O
the ? ? O
interconversion ? ? O
of ? ? O
fructose-6-P ? ? O
and ? ? O
mannose-6-P ? ? O
. ? ? O

The 18928705 ? O
clinical ? ? O
phenotype ? ? O
is ? ? O
characterized ? ? O
by ? ? O
gastro-intestinal ? ? I-disease
and ? ? I-disease
hepatic ? ? I-disease
symptoms ? ? I-disease
. ? ? O

In 18928705 ? O
contrast ? ? O
to ? ? O
most ? ? O
CDG ? ? I-disease
patients ? ? O
, ? ? O
there ? ? O
is ? ? O
no ? ? I-disease
neurological ? ? I-disease
affectation ? ? I-disease
. ? ? O

It 18928705 ? O
's ? ? O
a ? ? O
mannose ? ? I-treatment
treatable ? ? I-treatment
disorder ? ? O
. ? ? O

We 18928705 ? O
report ? ? O
the ? ? O
first ? ? O
recognised ? ? O
case ? ? O
of ? ? O
CDG ? ? I-disease
Ib ? ? I-disease
in ? ? O
Spain ? ? O
. ? ? O

He 18928705 ? O
presented ? ? O
at ? ? O
6 ? ? O
months ? ? O
with ? ? O
hypoglycaemia ? ? I-disease
, ? ? O
failure ? ? I-disease
to ? ? I-disease
thrive ? ? I-disease
and ? ? O
hypertransaminasaemia ? ? I-disease
. ? ? O

He 18928705 ? O
subsequently ? ? O
developed ? ? O
an ? ? O
enteropathy ? ? I-disease
with ? ? I-disease
subtotal ? ? I-disease
villous ? ? I-disease
atrophy ? ? I-disease
on ? ? O
biopsy ? ? O
. ? ? O

The 18928705 ? O
% ? ? O
CDT ? ? I-disease
was ? ? I-disease
very ? ? I-disease
high ? ? I-disease
and ? ? O
he ? ? O
presented ? ? O
with ? ? O
a ? ? O
type ? ? I-disease
1 ? ? I-disease
pattern ? ? I-disease
in ? ? I-disease
transferrin ? ? I-disease
isoelectric ? ? I-disease
focusing ? ? I-disease
. ? ? O

PMI 18928705 ? I-disease
activity ? ? I-disease
in ? ? I-disease
fibroblasts ? ? I-disease
was ? ? I-disease
very ? ? I-disease
deficient ? ? I-disease
. ? ? O

Mutations 18928705 ? I-disease
in ? ? I-disease
MPI ? ? I-disease
gene ? ? I-disease
at ? ? I-disease
R219Q ? ? I-disease
and ? ? I-disease
R56fs ? ? I-disease
were ? ? O
found ? ? O
. ? ? O

Clinical 18928705 ? O
and ? ? O
biochemical ? ? O
parameters ? ? O
normalised ? ? O
after ? ? O
treatment ? ? O
with ? ? O
mannose ? ? I-treatment
1 ? ? I-treatment
g ? ? I-treatment
/ ? ? I-treatment
kg ? ? I-treatment
/ ? ? I-treatment
day ? ? I-treatment
in ? ? I-treatment
5 ? ? I-treatment
doses ? ? I-treatment
. ? ? O

CDG 18928705 ? I-disease
Ib ? ? I-disease
should ? ? O
be ? ? O
considered ? ? O
in ? ? O
patients ? ? O
with ? ? O
hypoglycaemia ? ? I-disease
, ? ? O
liver ? ? I-disease
disease ? ? I-disease
, ? ? O
enteropathy ? ? I-disease
and ? ? O
hypercoagulability ? ? I-disease
, ? ? O
in ? ? O
the ? ? O
absence ? ? O
of ? ? O
other ? ? O
common ? ? O
causes ? ? O
, ? ? O
and ? ? O
particularly ? ? O
if ? ? O
some ? ? O
of ? ? O
them ? ? O
are ? ? O
combined ? ? O
. ? ? O

Congenital 19101518 ? I-disease
disorder ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
Ia ? ? I-disease
: ? ? O
new ? ? O
differentially ? ? O
expressed ? ? O
proteins ? ? O
identified ? ? O
by ? ? O
2-DE ? ? O
. ? ? O

Congenital 19101518 ? I-disease
disorders ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
( ? ? O
CDG ? ? I-disease
) ? ? O
comprise ? ? O
a ? ? O
family ? ? O
of ? ? O
inherited ? ? I-disease
multisystemic ? ? I-disease
disorders ? ? I-disease
resulting ? ? O
from ? ? O
the ? ? O
deficiency ? ? O
of ? ? O
glycosylation ? ? O
pathways ? ? O
. ? ? O

N-glycosylation 19101518 ? O
defects ? ? O
are ? ? O
classified ? ? O
as ? ? O
two ? ? O
biochemical ? ? O
and ? ? O
genetic ? ? O
established ? ? O
types ? ? O
, ? ? O
of ? ? O
which ? ? O
CDG-Ia ? ? I-disease
is ? ? O
the ? ? O
most ? ? O
frequent ? ? O
. ? ? O

We 19101518 ? O
performed ? ? O
2-DE ? ? O
proteomic ? ? O
analysis ? ? O
on ? ? O
serum ? ? O
from ? ? O
two ? ? O
functional ? ? O
hemizygous ? ? O
CDG-Ia ? ? I-disease
patients ? ? O
bearing ? ? O
T237M ? ? O
and ? ? O
D65Y ? ? O
missense ? ? O
changes ? ? O
. ? ? O

Comparative 19101518 ? O
analysis ? ? O
of ? ? O
control ? ? O
/ ? ? O
patient ? ? O
serum ? ? O
proteome ? ? O
allowed ? ? O
us ? ? O
to ? ? O
identify ? ? O
differential ? ? O
expression ? ? O
of ? ? O
14 ? ? O
proteins ? ? O
. ? ? O

The 19101518 ? O
most ? ? O
remarkable ? ? O
groups ? ? O
included ? ? O
proteins ? ? O
involved ? ? O
in ? ? O
immune ? ? O
response ? ? O
, ? ? O
coagulation ? ? O
mechanism ? ? O
and ? ? O
tissue ? ? O
protection ? ? O
against ? ? O
oxidative ? ? O
stress ? ? O
. ? ? O

The 19101518 ? O
patient ? ? O
bearing ? ? O
D65Y ? ? O
mutation ? ? O
had ? ? O
less ? ? O
favourable ? ? O
clinical ? ? O
outcome ? ? O
and ? ? O
showed ? ? O
more ? ? O
abnormalities ? ? O
in ? ? O
the ? ? O
spot ? ? O
patterns ? ? O
, ? ? O
suggesting ? ? O
that ? ? O
the ? ? O
proteomic ? ? O
results ? ? O
might ? ? O
also ? ? O
be ? ? O
correlated ? ? O
with ? ? O
the ? ? O
phenotype ? ? O
of ? ? O
CDG ? ? I-disease
patients ? ? O
. ? ? O

This 19101518 ? O
study ? ? O
describes ? ? O
for ? ? O
the ? ? O
first ? ? O
time ? ? O
the ? ? O
differential ? ? O
expression ? ? O
of ? ? O
alpha ? ? I-gene
( ? ? I-gene
2 ? ? I-gene
) ? ? I-gene
-macroglobulin ? ? I-gene
, ? ? O
afamin ? ? I-gene
, ? ? O
fibrin ? ? I-gene
and ? ? O
fibrinogen ? ? I-gene
in ? ? O
CDG ? ? I-disease
disorder ? ? O
and ? ? O
shows ? ? O
how ? ? O
the ? ? O
proteomic ? ? O
approach ? ? O
might ? ? O
be ? ? O
useful ? ? O
for ? ? O
understanding ? ? O
its ? ? O
physiopathology ? ? O
. ? ? O

Comparison 19608465 ? O
between ? ? O
high ? ? O
performance ? ? O
liquid ? ? O
chromatography ? ? O
and ? ? O
capillary ? ? O
zone ? ? O
electrophoresis ? ? O
for ? ? O
the ? ? O
diagnosis ? ? O
of ? ? O
congenital ? ? I-disease
disorders ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
. ? ? O

Transferrin 19608465 ? I-gene
isoelectric ? ? O
focusing ? ? O
( ? ? O
IEF ? ? O
) ? ? O
is ? ? O
the ? ? O
most ? ? O
widely ? ? O
used ? ? O
method ? ? O
to ? ? O
screen ? ? O
for ? ? O
congenital ? ? I-disease
disorders ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
( ? ? O
CDG ? ? I-disease
) ? ? O
. ? ? O

Our 19608465 ? O
aim ? ? O
was ? ? O
to ? ? O
compare ? ? O
high ? ? O
performance ? ? O
liquid ? ? O
chromatography ? ? O
( ? ? O
HPLC ? ? O
) ? ? O
and ? ? O
capillary ? ? O
zone ? ? O
electrophoresis ? ? O
( ? ? O
CZE ? ? O
) ? ? O
procedures ? ? O
for ? ? O
serum ? ? O
sialotransferrin ? ? I-gene
analysis ? ? O
. ? ? O

58 19608465 ? O
serum ? ? O
samples ? ? O
were ? ? O
processed ? ? O
both ? ? O
by ? ? O
CZE ? ? O
and ? ? O
HPLC ? ? O
: ? ? O
35 ? ? O
were ? ? O
from ? ? O
paediatric ? ? O
controls ? ? O
, ? ? O
18 ? ? O
from ? ? O
patients ? ? O
with ? ? O
an ? ? O
altered ? ? I-disease
sialotransferrin ? ? I-disease
IEF ? ? I-disease
pattern ? ? I-disease
and ? ? O
5 ? ? O
were ? ? O
transferrin ? ? I-gene
variant ? ? O
samples ? ? O
. ? ? O

HPLC 19608465 ? O
analysis ? ? O
was ? ? O
performed ? ? O
with ? ? O
an ? ? O
anion-exchange ? ? O
column ? ? O
with ? ? O
spectrophotometric ? ? O
detection ? ? O
at ? ? O
470 ? ? O
nm ? ? O
. ? ? O

CZE 19608465 ? O
analysis ? ? O
was ? ? O
done ? ? O
using ? ? O
the ? ? O
commercial ? ? O
CEofix-CDT ? ? O
kit ? ? O
with ? ? O
spectrophotometric ? ? O
detection ? ? O
at ? ? O
200 ? ? O
nm ? ? O
. ? ? O

Passing-Bablok 19608465 ? O
regression ? ? O
analysis ? ? O
showed ? ? O
good ? ? O
agreement ? ? O
for ? ? O
tri- ? ? I-gene
, ? ? I-gene
tetra- ? ? I-gene
and ? ? I-gene
penta-sialotransferrin ? ? I-gene
by ? ? O
both ? ? O
procedures ? ? O
. ? ? O

But 19608465 ? O
for ? ? O
disialotransferrin ? ? I-gene
, ? ? O
higher ? ? O
values ? ? O
were ? ? O
observed ? ? O
by ? ? O
the ? ? O
HPLC ? ? O
procedure ? ? O
. ? ? O

The 19608465 ? O
HPLC ? ? O
and ? ? O
CZE ? ? O
methods ? ? O
allowed ? ? O
reproducible ? ? O
separation ? ? O
and ? ? O
analysis ? ? O
of ? ? O
single ? ? O
transferrin ? ? I-gene
glycoforms ? ? O
with ? ? O
similar ? ? O
peak ? ? O
patterns ? ? O
. ? ? O

All 19608465 ? O
patients ? ? O
presented ? ? O
values ? ? O
outside ? ? O
the ? ? O
range ? ? O
established ? ? O
in ? ? O
our ? ? O
control ? ? O
population ? ? O
either ? ? O
by ? ? O
HPLC ? ? O
or ? ? O
by ? ? O
CZE ? ? O
, ? ? O
even ? ? O
in ? ? O
patients ? ? O
with ? ? O
moderate ? ? O
forms ? ? O
of ? ? O
CDG ? ? I-disease
that ? ? O
had ? ? O
been ? ? O
difficult ? ? O
to ? ? O
detect ? ? O
by ? ? O
IEF ? ? O
. ? ? O

In 19608465 ? O
conclusion ? ? O
, ? ? O
measurement ? ? O
of ? ? O
sialotransferrin ? ? I-gene
isoforms ? ? O
and ? ? O
interpretation ? ? O
using ? ? O
method-specific ? ? O
reference ? ? O
values ? ? O
may ? ? O
offer ? ? O
some ? ? O
advantages ? ? O
for ? ? O
the ? ? O
diagnosis ? ? O
of ? ? O
CDG ? ? I-disease
as ? ? O
compared ? ? O
with ? ? O
the ? ? O
standard ? ? O
IEF ? ? O
procedure ? ? O
. ? ? O

Autosomal 22242004 ? I-disease
recessive ? ? I-disease
dilated ? ? I-disease
cardiomyopathy ? ? I-disease
due ? ? O
to ? ? O
DOLK ? ? I-gene
mutations ? ? O
results ? ? O
from ? ? O
abnormal ? ? O
dystroglycan ? ? O
O-mannosylation ? ? O
. ? ? O

Genetic 22242004 ? O
causes ? ? O
for ? ? O
autosomal ? ? I-disease
recessive ? ? I-disease
forms ? ? I-disease
of ? ? I-disease
dilated ? ? I-disease
cardiomyopathy ? ? I-disease
( ? ? O
DCM ? ? I-disease
) ? ? O
are ? ? O
only ? ? O
rarely ? ? O
identified ? ? O
, ? ? O
although ? ? O
they ? ? O
are ? ? O
thought ? ? O
to ? ? O
contribute ? ? O
considerably ? ? O
to ? ? O
sudden ? ? I-disease
cardiac ? ? I-disease
death ? ? I-disease
and ? ? O
heart ? ? I-disease
failure ? ? I-disease
, ? ? O
especially ? ? O
in ? ? O
young ? ? O
children ? ? O
. ? ? O

Here 22242004 ? O
, ? ? O
we ? ? O
describe ? ? O
11 ? ? O
young ? ? O
patients ? ? O
( ? ? O
5-13 ? ? O
years ? ? O
) ? ? O
with ? ? O
a ? ? O
predominant ? ? O
presentation ? ? O
of ? ? O
dilated ? ? I-disease
cardiomyopathy ? ? I-disease
( ? ? O
DCM ? ? I-disease
) ? ? O
. ? ? O

Metabolic 22242004 ? O
investigations ? ? O
showed ? ? O
deficient ? ? I-disease
protein ? ? I-disease
N-glycosylation ? ? I-disease
, ? ? O
leading ? ? O
to ? ? O
a ? ? O
diagnosis ? ? O
of ? ? O
Congenital ? ? I-disease
Disorders ? ? I-disease
of ? ? I-disease
Glycosylation ? ? I-disease
( ? ? O
CDG ? ? I-disease
) ? ? O
. ? ? O

Homozygosity 22242004 ? O
mapping ? ? O
in ? ? O
the ? ? O
consanguineous ? ? O
families ? ? O
showed ? ? O
a ? ? O
locus ? ? O
with ? ? O
two ? ? O
known ? ? O
genes ? ? O
in ? ? O
the ? ? O
N-glycosylation ? ? O
pathway ? ? O
. ? ? O

In 22242004 ? O
all ? ? O
individuals ? ? O
, ? ? O
pathogenic ? ? O
mutations ? ? O
were ? ? O
identified ? ? O
in ? ? O
DOLK ? ? I-gene
, ? ? O
encoding ? ? O
the ? ? O
dolichol ? ? I-gene
kinase ? ? I-gene
responsible ? ? O
for ? ? O
formation ? ? O
of ? ? O
dolichol-phosphate ? ? O
. ? ? O

Enzyme 22242004 ? O
analysis ? ? O
in ? ? O
patients ? ? O
' ? ? O
fibroblasts ? ? O
confirmed ? ? O
a ? ? O
dolichol ? ? I-disease
kinase ? ? I-disease
deficiency ? ? I-disease
in ? ? O
all ? ? O
families ? ? O
. ? ? O

In 22242004 ? O
comparison ? ? O
with ? ? O
the ? ? O
generally ? ? O
multisystem ? ? I-disease
presentation ? ? I-disease
in ? ? O
CDG ? ? I-disease
, ? ? O
the ? ? O
nonsyndromic ? ? I-disease
DCM ? ? I-disease
in ? ? O
several ? ? O
individuals ? ? O
was ? ? O
remarkable ? ? O
. ? ? O

Investigation 22242004 ? O
of ? ? O
other ? ? O
dolichol-phosphate ? ? O
dependent ? ? O
glycosylation ? ? O
pathways ? ? O
in ? ? O
biopsied ? ? O
heart ? ? O
tissue ? ? O
indicated ? ? O
reduced ? ? I-disease
O-mannosylation ? ? I-disease
of ? ? I-disease
alpha-dystroglycan ? ? I-disease
with ? ? O
concomitant ? ? O
functional ? ? O
loss ? ? O
of ? ? O
its ? ? O
laminin-binding ? ? O
capacity ? ? O
, ? ? O
which ? ? O
has ? ? O
been ? ? O
linked ? ? O
to ? ? O
DCM ? ? I-disease
. ? ? O

We 22242004 ? O
thus ? ? O
identified ? ? O
a ? ? O
combined ? ? O
deficiency ? ? I-disease
of ? ? I-disease
protein ? ? I-disease
N-glycosylation ? ? I-disease
and ? ? I-disease
alpha-dystroglycan ? ? I-disease
O-mannosylation ? ? I-disease
in ? ? O
patients ? ? O
with ? ? O
nonsyndromic ? ? I-disease
DCM ? ? I-disease
due ? ? O
to ? ? O
autosomal ? ? O
recessive ? ? O
DOLK ? ? I-gene
mutations ? ? O
. ? ? O

Analysis 23038983 ? O
of ? ? O
congenital ? ? I-disease
disorder ? ? I-disease
of ? ? I-disease
glycosylation-Id ? ? I-disease
in ? ? O
a ? ? O
yeast ? ? O
model ? ? O
system ? ? O
shows ? ? O
diverse ? ? O
site-specific ? ? O
under-glycosylation ? ? O
of ? ? O
glycoproteins ? ? O
. ? ? O

Asparagine-linked 23038983 ? I-disease
glycosylation ? ? I-disease
is ? ? O
a ? ? O
common ? ? O
post-translational ? ? O
modification ? ? O
of ? ? O
proteins ? ? O
in ? ? O
eukaryotes ? ? O
. ? ? O

Mutations 23038983 ? O
in ? ? O
the ? ? O
human ? ? O
ALG3 ? ? I-gene
gene ? ? O
cause ? ? O
changed ? ? O
levels ? ? O
and ? ? O
altered ? ? O
glycan ? ? O
structures ? ? O
on ? ? O
mature ? ? O
glycoproteins ? ? O
and ? ? O
are ? ? O
the ? ? O
cause ? ? O
of ? ? O
a ? ? O
severe ? ? O
congenital ? ? I-disease
disorder ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
( ? ? O
CDG-Id ? ? I-disease
) ? ? O
. ? ? O

Diverse 23038983 ? O
glycoproteins ? ? O
are ? ? O
also ? ? O
under-glycosylated ? ? O
in ? ? O
Saccharomyces ? ? O
cerevisae ? ? O
alg3 ? ? I-gene
mutants ? ? O
. ? ? O

Here 23038983 ? O
we ? ? O
analyzed ? ? O
site-specific ? ? O
glycosylation ? ? O
occupancy ? ? O
in ? ? O
this ? ? O
yeast ? ? O
model ? ? O
system ? ? O
using ? ? O
peptide-N-glycosidase ? ? O
F ? ? O
to ? ? O
label ? ? O
glycosylation ? ? O
sites ? ? O
with ? ? O
an ? ? O
asparagine-aspartate ? ? O
conversion ? ? O
that ? ? O
creates ? ? O
a ? ? O
new ? ? O
endoproteinase ? ? O
AspN ? ? I-gene
cleavage ? ? O
site ? ? O
, ? ? O
followed ? ? O
by ? ? O
proteolytic ? ? O
digestion ? ? O
, ? ? O
and ? ? O
detection ? ? O
of ? ? O
peptides ? ? O
and ? ? O
glycopeptides ? ? O
by ? ? O
LC-ESI-MS ? ? O
/ ? ? O
MS. ? ? O
We ? ? O
used ? ? O
this ? ? O
analytical ? ? O
method ? ? O
to ? ? O
identify ? ? O
and ? ? O
measure ? ? O
site-specific ? ? O
glycosylation ? ? O
occupancy ? ? O
in ? ? O
alg3 ? ? I-gene
mutant ? ? O
and ? ? O
wild ? ? O
type ? ? O
yeast ? ? O
strains ? ? O
. ? ? O

We 23038983 ? O
found ? ? O
decreased ? ? O
site-specific ? ? O
N-glycosylation ? ? O
occupancy ? ? O
in ? ? O
the ? ? O
alg3 ? ? I-gene
knockout ? ? O
strain ? ? O
preferentially ? ? O
at ? ? O
Asn-Xaa-Ser ? ? O
sequences ? ? O
located ? ? O
in ? ? O
secondary ? ? O
structural ? ? O
elements ? ? O
, ? ? O
features ? ? O
previously ? ? O
associated ? ? O
with ? ? O
poor ? ? O
glycosylation ? ? O
efficiency ? ? O
. ? ? O

Furthermore 23038983 ? O
, ? ? O
we ? ? O
identified ? ? O
26 ? ? O
previously ? ? O
experimentally ? ? O
unverified ? ? O
glycosylation ? ? O
sites ? ? O
. ? ? O

Our 23038983 ? O
results ? ? O
provide ? ? O
insights ? ? O
into ? ? O
the ? ? O
underlying ? ? O
mechanisms ? ? O
of ? ? O
disease ? ? O
in ? ? O
CDG-Id ? ? I-disease
, ? ? O
and ? ? O
our ? ? O
methodology ? ? O
will ? ? O
be ? ? O
useful ? ? O
in ? ? O
site-specific ? ? O
glycosylation ? ? O
analysis ? ? O
in ? ? O
many ? ? O
model ? ? O
systems ? ? O
and ? ? O
clinical ? ? O
applications ? ? O
. ? ? O

Heritable 23059969 ? O
disorders ? ? O
in ? ? O
the ? ? O
metabolism ? ? O
of ? ? O
the ? ? O
dolichols ? ? O
: ? ? O
A ? ? O
bridge ? ? O
from ? ? O
sterol ? ? O
biosynthesis ? ? O
to ? ? O
molecular ? ? O
glycosylation ? ? O
. ? ? O

Dolichols 23059969 ? O
, ? ? O
polyisoprene ? ? O
alcohols ? ? O
derived ? ? O
from ? ? O
the ? ? O
mevalonate ? ? O
pathway ? ? O
of ? ? O
cholesterol ? ? O
synthesis ? ? O
, ? ? O
serve ? ? O
as ? ? O
carriers ? ? O
of ? ? I-disease
glycan ? ? O
precursors ? ? O
for ? ? O
the ? ? O
formation ? ? O
of ? ? O
oligosaccharides ? ? O
important ? ? O
in ? ? O
protein ? ? O
glycosylation ? ? O
. ? ? O

Seven 23059969 ? O
autosomal-recessively ? ? I-disease
inherited ? ? I-disease
disorders ? ? I-disease
in ? ? I-disease
the ? ? I-disease
metabolism ? ? I-disease
( ? ? I-disease
synthesis ? ? I-disease
, ? ? I-disease
utilization ? ? I-disease
, ? ? I-disease
recycling ? ? I-disease
) ? ? I-disease
of ? ? I-disease
the ? ? I-disease
dolichols ? ? I-disease
have ? ? O
recently ? ? O
been ? ? O
described ? ? O
, ? ? O
and ? ? O
all ? ? O
are ? ? O
associated ? ? O
with ? ? O
decreased ? ? O
lipid-linked ? ? O
oligosaccharides ? ? O
leading ? ? O
to ? ? O
underglycosylated ? ? O
proteins ? ? O
or ? ? O
lipids ? ? O
which ? ? O
facilitate ? ? O
their ? ? O
detection ? ? O
in ? ? O
the ? ? O
diagnostic ? ? O
laboratory ? ? O
. ? ? O

Multisystem 23059969 ? O
pathology ? ? O
encompasses ? ? O
developmental ? ? I-disease
delays ? ? I-disease
and ? ? O
eye ? ? I-disease
, ? ? I-disease
heart ? ? I-disease
, ? ? I-disease
skin ? ? I-disease
and ? ? I-disease
muscle ? ? I-disease
abnormalities ? ? I-disease
; ? ? O
outcomes ? ? O
range ? ? O
from ? ? O
death ? ? I-disease
in ? ? O
infancy ? ? O
to ? ? O
mild ? ? I-disease
, ? ? I-disease
late-onset ? ? I-disease
disease ? ? I-disease
. ? ? O

Proteomic 24388574 ? O
analysis ? ? O
of ? ? O
platelet ? ? O
N-glycoproteins ? ? O
in ? ? O
PMM2-CDG ? ? I-disease
patients ? ? O
. ? ? O

PMM2-CDG 24388574 ? I-disease
, ? ? O
the ? ? O
most ? ? O
frequent ? ? O
congenital ? ? I-disease
disorder ? ? I-disease
of ? ? I-disease
N-glycosylation ? ? I-disease
, ? ? O
is ? ? O
an ? ? O
autosomal ? ? I-disease
recessive ? ? I-disease
disease ? ? I-disease
with ? ? O
a ? ? O
multisystem ? ? I-disease
presentation ? ? I-disease
. ? ? O

PMM2-CDG 24388574 ? I-disease
patients ? ? O
show ? ? O
an ? ? I-disease
increased ? ? I-disease
risk ? ? I-disease
for ? ? I-disease
thrombosis ? ? I-disease
, ? ? O
which ? ? O
might ? ? O
be ? ? O
in ? ? O
part ? ? O
due ? ? O
to ? ? O
spontaneous ? ? O
platelet ? ? O
aggregations ? ? O
as ? ? O
previously ? ? O
described ? ? O
. ? ? O

A 24388574 ? O
potential ? ? O
hypoglycosylation ? ? I-disease
of ? ? I-disease
platelet ? ? I-disease
proteins ? ? I-disease
in ? ? O
these ? ? O
patients ? ? O
might ? ? O
explain ? ? O
this ? ? O
increased ? ? O
reactivity ? ? O
, ? ? O
as ? ? O
removal ? ? O
of ? ? O
sialic ? ? O
acid ? ? O
from ? ? O
platelets ? ? O
, ? ? O
particularly ? ? O
of ? ? O
GPIbalpha ? ? I-gene
, ? ? O
leads ? ? O
to ? ? O
enhance ? ? O
platelet ? ? O
aggregation ? ? O
and ? ? O
clearance ? ? O
from ? ? O
the ? ? O
circulation ? ? O
. ? ? O

This 24388574 ? O
study ? ? O
is ? ? O
the ? ? O
first ? ? O
one ? ? O
that ? ? O
has ? ? O
evaluated ? ? O
the ? ? O
glycosylation ? ? O
status ? ? O
of ? ? O
platelet ? ? O
proteins ? ? O
in ? ? O
6 ? ? O
PMM2-CDG ? ? I-disease
patients ? ? O
using ? ? O
different ? ? O
approaches ? ? O
including ? ? O
immunoblot ? ? O
, ? ? O
RCA120 ? ? O
lectin ? ? O
binding ? ? O
to ? ? O
platelets ? ? O
and ? ? O
expression ? ? O
of ? ? O
different ? ? O
membrane ? ? O
platelet ? ? O
N-glycoproteins ? ? O
by ? ? O
flow ? ? O
cytometry ? ? O
, ? ? O
as ? ? O
well ? ? O
as ? ? O
by ? ? O
platelet ? ? O
N-glycoproteome ? ? O
analysis ? ? O
. ? ? O

RCA120 24388574 ? O
lectin ? ? O
binding ? ? O
to ? ? O
the ? ? O
platelet ? ? O
membrane ? ? O
of ? ? O
PMM2-CDG ? ? I-disease
patients ? ? O
showed ? ? O
evidence ? ? O
for ? ? O
decreased ? ? O
sialic ? ? O
acid ? ? O
content ? ? O
. ? ? O

However 24388574 ? O
, ? ? O
immunoblot ? ? O
and ? ? O
flow ? ? O
cytometric ? ? O
analysis ? ? O
of ? ? O
different ? ? O
platelet ? ? O
N-glycoproteins ? ? O
, ? ? O
together ? ? O
with ? ? O
the ? ? O
more ? ? O
sensitive ? ? O
2D-DIGE ? ? O
analysis ? ? O
, ? ? O
suggest ? ? O
that ? ? O
platelet ? ? O
N-glycoproteins ? ? O
, ? ? O
including ? ? O
GPIbalpha ? ? I-gene
, ? ? O
seem ? ? O
to ? ? O
be ? ? O
neither ? ? O
quantitatively ? ? O
nor ? ? O
qualitatively ? ? O
significantly ? ? O
affected ? ? O
. ? ? O

The 24388574 ? O
increased ? ? O
binding ? ? O
of ? ? O
RCA120 ? ? O
lectin ? ? O
could ? ? O
be ? ? O
explained ? ? O
by ? ? O
the ? ? O
abnormal ? ? O
glycosylation ? ? O
of ? ? O
hepatic ? ? O
proteins ? ? O
being ? ? O
attached ? ? O
to ? ? O
the ? ? O
platelets ? ? O
. ? ? O

CONCLUSIONS 24388574 ? O
: ? ? O
This ? ? O
is ? ? O
the ? ? O
first ? ? O
study ? ? O
that ? ? O
has ? ? O
evaluated ? ? O
the ? ? O
platelet ? ? O
N-glycoproteome ? ? O
. ? ? O

Our 24388574 ? O
findings ? ? O
suggest ? ? O
that ? ? O
platelet ? ? I-disease
proteins ? ? I-disease
are ? ? I-disease
not ? ? I-disease
significantly ? ? I-disease
affected ? ? I-disease
in ? ? O
PMM2-CDG ? ? I-disease
patients ? ? O
. ? ? O

Further 24388574 ? O
studies ? ? O
are ? ? O
still ? ? O
warranted ? ? O
to ? ? O
unravel ? ? O
the ? ? O
mechanism ? ? O
( ? ? O
s ? ? O
) ? ? O
that ? ? O
increase ? ? O
( ? ? O
s ? ? O
) ? ? O
the ? ? O
risk ? ? O
of ? ? O
thrombosis ? ? I-disease
in ? ? O
these ? ? O
patients ? ? O
. ? ? O

Oxidoreductase 25135935 ? I-gene
activity ? ? O
is ? ? O
necessary ? ? O
for ? ? O
N-glycosylation ? ? O
of ? ? O
cysteine-proximal ? ? O
acceptor ? ? O
sites ? ? O
in ? ? O
glycoproteins ? ? O
. ? ? O

Stabilization 25135935 ? O
of ? ? O
protein ? ? O
tertiary ? ? O
structure ? ? O
by ? ? O
disulfides ? ? O
can ? ? O
interfere ? ? O
with ? ? O
glycosylation ? ? O
of ? ? O
acceptor ? ? O
sites ? ? O
( ? ? O
NXT ? ? O
/ ? ? O
S ? ? O
) ? ? O
in ? ? O
nascent ? ? O
polypeptides ? ? O
. ? ? O

Here 25135935 ? O
, ? ? O
we ? ? O
show ? ? O
that ? ? O
MagT1 ? ? I-gene
, ? ? O
an ? ? O
ER-localized ? ? O
thioredoxin ? ? I-gene
homologue ? ? O
, ? ? O
is ? ? O
a ? ? O
subunit ? ? O
of ? ? O
the ? ? O
STT3B ? ? I-gene
isoform ? ? O
of ? ? O
the ? ? O
oligosaccharyltransferase ? ? I-gene
( ? ? O
OST ? ? I-gene
) ? ? O
. ? ? O

The 25135935 ? O
lumenally ? ? O
oriented ? ? O
active ? ? O
site ? ? O
CVVC ? ? O
motif ? ? O
in ? ? O
MagT1 ? ? I-gene
is ? ? O
required ? ? O
for ? ? O
glycosylation ? ? O
of ? ? O
STT3B-dependent ? ? I-gene
acceptor ? ? O
sites ? ? O
including ? ? O
those ? ? O
that ? ? O
are ? ? O
closely ? ? O
bracketed ? ? O
by ? ? O
disulfides ? ? O
or ? ? O
contain ? ? O
cysteine ? ? O
as ? ? O
the ? ? O
internal ? ? O
residue ? ? O
( ? ? O
NCT ? ? O
/ ? ? O
S ? ? O
) ? ? O
. ? ? O

The 25135935 ? O
MagT1- ? ? O
and ? ? O
STT3B-dependent ? ? I-gene
glycosylation ? ? O
of ? ? O
cysteine-proximal ? ? O
acceptor ? ? O
sites ? ? O
can ? ? O
be ? ? O
reduced ? ? O
by ? ? O
eliminating ? ? O
cysteine ? ? O
residues ? ? O
. ? ? O

The 25135935 ? O
predominant ? ? O
form ? ? O
of ? ? O
MagT1 ? ? I-gene
in ? ? O
vivo ? ? O
is ? ? O
oxidized ? ? O
, ? ? O
which ? ? O
is ? ? O
consistent ? ? O
with ? ? O
transient ? ? O
formation ? ? O
of ? ? O
mixed ? ? O
disulfides ? ? O
between ? ? O
MagT1 ? ? I-gene
and ? ? O
a ? ? O
glycoprotein ? ? O
substrate ? ? O
to ? ? O
facilitate ? ? O
access ? ? O
of ? ? O
STT3B ? ? I-gene
to ? ? O
unmodified ? ? O
acceptor ? ? O
sites ? ? O
. ? ? O

Cotranslational 25135935 ? O
N-glycosylation ? ? O
by ? ? O
the ? ? O
STT3A ? ? I-gene
isoform ? ? O
of ? ? O
the ? ? O
OST ? ? I-gene
, ? ? O
which ? ? O
lacks ? ? O
MagT1 ? ? I-gene
, ? ? O
allows ? ? O
efficient ? ? O
modification ? ? O
of ? ? O
acceptor ? ? O
sites ? ? O
in ? ? O
cysteine-rich ? ? O
protein ? ? O
domains ? ? O
before ? ? O
disulfide ? ? O
bond ? ? O
formation ? ? O
. ? ? O

Thus 25135935 ? O
, ? ? O
mammalian ? ? O
cells ? ? O
use ? ? O
two ? ? O
mechanisms ? ? O
to ? ? O
achieve ? ? O
N-glycosylation ? ? O
of ? ? O
cysteine ? ? O
proximal ? ? O
acceptor ? ? O
sites ? ? O
. ? ? O

Cell 25379387 ? O
surface ? ? O
N-glycans ? ? O
influence ? ? O
the ? ? O
level ? ? O
of ? ? O
functional ? ? O
E-cadherin ? ? I-gene
at ? ? O
the ? ? O
cell-cell ? ? O
border ? ? O
. ? ? O

E-cadherin 25379387 ? I-gene
is ? ? O
crucial ? ? O
for ? ? O
adhesion ? ? O
of ? ? O
cells ? ? O
to ? ? O
each ? ? O
other ? ? O
and ? ? O
thereby ? ? O
development ? ? O
and ? ? O
maintenance ? ? O
of ? ? O
tissue ? ? O
. ? ? O

While 25379387 ? O
it ? ? O
is ? ? O
has ? ? O
been ? ? O
established ? ? O
that ? ? O
N-glycans ? ? O
inside ? ? O
the ? ? O
cell ? ? O
impact ? ? O
the ? ? O
level ? ? O
of ? ? O
E-cadherin ? ? I-gene
at ? ? O
the ? ? O
cell ? ? O
surface ? ? O
of ? ? O
epithelial-derived ? ? O
cells ? ? O
, ? ? O
it ? ? O
is ? ? O
unclear ? ? O
whether ? ? O
N-glycans ? ? O
outside ? ? O
the ? ? O
cell ? ? O
control ? ? O
the ? ? O
clustering ? ? O
of ? ? O
E-cadherin ? ? I-gene
at ? ? O
the ? ? O
cell-cell ? ? O
border ? ? O
. ? ? O

Here 25379387 ? O
, ? ? O
we ? ? O
demonstrate ? ? O
reduction ? ? O
of ? ? O
N-glycans ? ? O
at ? ? O
the ? ? O
cell ? ? O
surface ? ? O
weakened ? ? O
the ? ? O
recruitment ? ? O
and ? ? O
retention ? ? O
of ? ? O
E-cadherin ? ? I-gene
at ? ? O
the ? ? O
cell-cell ? ? O
border ? ? O
, ? ? O
and ? ? O
consequently ? ? O
reduced ? ? O
the ? ? O
strength ? ? O
of ? ? O
cell-cell ? ? O
interactions ? ? O
. ? ? O

We 25379387 ? O
conclude ? ? O
that ? ? O
N-glycans ? ? O
at ? ? O
the ? ? O
cell ? ? O
surface ? ? O
are ? ? O
tightly ? ? O
linked ? ? O
to ? ? O
the ? ? O
placement ? ? O
of ? ? O
E-cadherin ? ? I-gene
at ? ? O
the ? ? O
cell-cell ? ? O
border ? ? O
and ? ? O
thereby ? ? O
control ? ? O
E-cadherin ? ? I-gene
mediated ? ? O
cell-cell ? ? O
adhesion ? ? O
. ? ? O

